INS and diabetes mellitus: Although this sample design might appear to reduce the statistical power, it was deliberately chosen to align with ADA guidelines (4), which recommend that real-time continuous glucose monitoring or intermittently scanned continuous glucose monitoring be offered to adults with diabetes who are on multiple daily injections or continuous subcutaneous insulin infusion and are capable of using these devices safely.